Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation

被引:0
|
作者
LI Min ZHANG Li-ping YANG Lu Department of Anesthesiology.Peking University Third Hospital
机构
关键词
liver transplantation; fluid therapy; coagulation; blood;
D O I
暂无
中图分类号
R657.3 [肝及肝管];
学科分类号
1002 ; 100210 ;
摘要
Background There have been many studies investigating the impact of the model for end-stage liver disease(MELD)score on predicting post-transplant outcome.But it is unclear whether MELD is correlated to intraoperative fluid therapyand coagulation status.We investigated the relationship between the severity of liver diseases as measured by MELDscore and intraoperative fluid requirements and the changes of coagulation characteristics.Methods Ninety patients were included in this retrospective study.The patients were stratified into three groupsaccording to the MELD scores:<15(low),15-25(medium)and>25(high).Intraoperatively,volume was restored withallogeneic and/or salvaged red blood cells(RBC),fresh-frozen plasma(FFP),platelet and other types of fluids accordingto hemodynamic data,hematocrit,and clotting data.Intraoperative coagulation data,blood requirements and other fluidsadministered were compared among the 3 groups.Results Before surgery,in addition to the three variables used to calculate MELD scores in other baseline laboratoryvalues,including ratio of activated partial thromboplastin time(R-APTT),D-Dimer,hematocrit,platelet and blood ureanitrogen(BUN)were significantly different among the 3 groups.The blood loss increased with increasing MELD.Thevolume of RBC(allogeneinc,salvaged and total),FFP,platelet and the total volume of transfusion were also significantlydifferent among the three groups(P<0.01).The requirements for prothrombin complex and fibrinogen showed a similarpattern.During operation,the changing trends of each coagulation variable were different.Compared with baseline,during each intraoperative stage,INR and R-APPT increased in the low MELD group.While in the medium MELD andhigh MELD groups,INR did not changed significantly during the operation,and R-APPT significantly increased only afterrepeffusion.Conclusions This study provided some useful information for perioperative management of patients undergoing livertransplantation.Careful preoperative planning and resource preparation are crucial for patients with high MELD scores.Close communication between surgeon,anesthesiologist and the transfusion staff of blood bank before and duringsurgery should be stressed.
引用
收藏
页码:1963 / 1968
页数:6
相关论文
共 50 条
  • [41] Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
    Raza, Muhammad H.
    Kwon, Yong
    Kobierski, Pierre
    Misra, Asish C.
    Lim, Angelina
    Goldbeck, Cameron
    Etesami, Kambiz
    Kohli, Rohit
    Emamaullee, Juliet
    LIVER TRANSPLANTATION, 2023, 29 (02) : 134 - 144
  • [42] SECTION 12. LIVING DONOR LIVER TRANSPLANTATION FOR PATIENTS WITH HIGH MODEL FOR END-STAGE LIVER DISEASE SCORES AND ACUTE LIVER FAILURE
    Kaido, Toshimi
    Tomiyama, Koji
    Ogawa, Kohei
    Fujimoto, Yasuhiro
    Ito, Takashi
    Mori, Akira
    Uemoto, Shinji
    TRANSPLANTATION, 2014, 97 (08) : S46 - S47
  • [43] The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy
    Dolejs, Scott C.
    Beane, Joal D.
    Kays, Joshua K.
    Ceppa, Eugene P.
    Zarzaur, Ben L.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (12): : 5192 - 5200
  • [44] The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy
    Scott C. Dolejs
    Joal D. Beane
    Joshua K. Kays
    Eugene P. Ceppa
    Ben L. Zarzaur
    Surgical Endoscopy, 2017, 31 : 5192 - 5200
  • [45] Stage of Cirrhosis Predicts the Risk of Liver-Related Death in Patients With Low Model for End-Stage Liver Disease Scores and Cirrhosis Awaiting Liver Transplantation
    Wedd, Joel
    Bambha, Kiran M.
    Stotts, Matt
    Laskey, Heather
    Colmenero, Jordi
    Gralla, Jane
    Biggins, Scott W.
    LIVER TRANSPLANTATION, 2014, 20 (10) : 1193 - 1201
  • [46] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [47] Living donor liver transplantation in high Model for End-Stage Liver Disease score patients
    Feng, Sandy
    LIVER TRANSPLANTATION, 2017, 23 : S9 - S21
  • [48] TRANSPLANT OUTCOME IN LIVER TRANSPLANTATION IN PATIENTS WITH HIGH SCORE OF MODEL FOR END-STAGE LIVER DISEASE
    Ferraz-Neto, Ben-Hur
    Villela Coelho, Maria Paula
    Hidalgo, Renato
    Neiva, Romerito Fonseca
    Harada, Kelly
    Schmidtbauer, Ivana
    Afonso, Rogerio Carballo
    TRANSPLANT INTERNATIONAL, 2013, 26 : 302 - 303
  • [49] Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation
    Foxton, Matthew R.
    Kendrick, Stewart
    Sizer, Elizabeth
    Muiesan, Paolo
    Rela, Mohammed
    Wendon, Julia
    Heaton, Nigel D.
    O'Grady, John G.
    Heneghan, Michael A.
    TRANSPLANT INTERNATIONAL, 2006, 19 (12) : 988 - 994
  • [50] Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score
    Gonzalez Martinez, S.
    Molina Raya, A.
    Becerra Massare, A.
    Muffak Granero, K.
    Villegas Herrera, T.
    Villar del Moral, J. M.
    Fundora Suarez, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 595 - 597